Search bioRxiv⌕ Search

Biology subjects

Xi, G.

Publications and source records attributed to Xi, G..

6 recordsLinked to original sources

scDisent: disentangled representation learning with causal structure for multi-omic single-cell analysis

Single-cell multi-omic technologies measure complementary aspects of cellular identity and regulatory state, yet most integration models compress these signals into one entangled latent space. Such representations are useful for clustering but poorly suited to regulator-centered interpretation or perturbation-oriented analysis. We present scDisent (https://github.com/xiguoren/scDisent), a generative framework that separates expression-associated variables (zexpr) from regulation-associated variables (zreg) and links them through a sparse directed mapping. scDisent combines modality-specific encoding, variational disentanglement, total-correlation and orthogonality regularization, and a Gumbel-gated causal module protected by detach-based gradient isolation. Across benchmark datasets with matched modalities, scDisent achieved the strongest clustering performance among the tested methods while exposing regulatory structure that competing integration models do not represent explicitly. The learned causal atlas remained sparse, perturbation analyses recovered biologically coherent lineage-associated programs, and branch-separation analyses showed that benchmark-label information concentrated in zexpr rather than zreg. These results position scDisent as a multi-omic representation model that improves both integration quality and biological interpretability

bioinformatics↗

Survey of Climate-structured Mycobiomes in Staple Maize: Implications for Endemic Keshan and Kashin-Beck Diseases

Keshan disease (KD) and Kashin-Beck disease (KBD) are geographically restricted disorders in rural China with overlapping environmental and dietary risk factors. Selenium deficiency alone cannot explain their regional heterogeneity. Maize, a dietary staple in endemic areas, represents a key exposure pathway for climate-sensitive foodborne fungi and their metabolites. We profiled maize-associated fungal communities from seven villages across KD-, KBD-, KD-KBD co-endemic, and non-endemic regions using ITS sequencing and integrative bioinformatics. Fungal diversity, composition, trophic structure, and predicted biosynthetic gene cluster potential differed markedly among regions. KD-endemic areas were enriched in saprotrophic taxa such as Penicillium and Aspergillus, KBD-endemic regions favored cold- and humidity-adapted fungi, and KD-KBD co-endemic areas exhibited the highest predicted mycotoxin potential. Fungal patterns were strongly associated with regional temperature and humidity. These findings support a climate-sensitive, foodborne exposome framework, suggesting that variation in maize-associated fungi may contribute to endemic disease risk and highlighting the need for fungal surveillance in public health strategies. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=115 SRC="FIGDIR/small/716289v1_ufig1.gif" ALT="Figure 1"> View larger version (43K): org.highwire.dtl.DTLVardef@2cf23borg.highwire.dtl.DTLVardef@d31e5aorg.highwire.dtl.DTLVardef@6dbcadorg.highwire.dtl.DTLVardef@7e0734_HPS_FORMAT_FIGEXP M_FIG C_FIG

ecology↗

Temporal evolution of hemodynamics in murine arteriovenous fistula: a micro-CT based computational fluid dynamics study

In this study, we investigated the hemodynamic characteristics of arteriovenous fistulae (AVF) in murine models using micro-CT based computational fluid dynamics (CFD). By combining high-resolution micro-CT imaging with ultrasound flow measurements, our methodology offers a cost-effective and efficient alternative to traditional MRI-based approaches. CFD simulations performed at 7 and 21 days post-surgery revealed significant temporal changes in both geometry and hemodynamics. Geometric analysis showed that: the proximal artery diameter increased from 0.29 mm to 0.38 mm, while the initial 2 mm fistula segment showed a 21.6% decrease (0.74 mm to 0.58 mm). Blood flow through the AVF nearly doubled from 1.33 mL/min to 2.57 mL/min. Time-averaged wall shear stress (TAWSS) peak values increased from 142 Pa (day 7) within the proximal artery to 200 Pa (day 21), in the stenotic region. The oscillatory shear index (OSI) showed marked elevation at the anastomosis (increasing from 0.22 to 0.48), indicating disturbed flow development. An inverse relationship between TAWSS and OSI was identified consistent with previous studies. Our methodology demonstrates the capability to analyze relationships between early hemodynamics and subsequent geometric changes. This approach could enable identification of regions susceptible to stenosis development and monitoring of AVF maturation, which could ultimately lead to quantitative metrics to evaluate surgical outcomes and early therapeutic interventions.

bioengineering↗

WDR82 mediated H3K4me3 is associated with tumor proliferation and therapeutic efficacy in pediatric high-grade gliomas

Pediatric high-grade gliomas (pHGGs) are common malignant brain tumors without effective treatment and poor patient survival. Abnormal posttranslational modification at the histone H3 tail plays critical roles in tumor cell malignancy. We have previously shown that trimethylation of lysine 4 at histone H3 (H3K4me3) plays a significant role in pediatric ependymoma malignancy and is associated with tumor therapeutic sensitivity. Here, we show that H3K4me3 and its methyltransferase WDR82 are elevated in pHGGs. Reduction of H3K4me3 by downregulating WDR82 decreases H3K4me3 promoter occupancy and expression of genes associated with stem cell features, cell proliferation, the cell cycle and DNA damage repair. Reduction of WDR82 mediated H3K4me3 increases the response of pediatric glioma cells to chemotherapy. These findings suggest that WDR82 mediated H3K4me3 is an important determinant of pediatric glioma malignancy and therapeutic response. This highlights the need for a more thorough understanding of the potential of WDR82 as an epigenetic target to increase therapeutic efficacy and improve prognosis for children with malignant gliomas.

cancer biology↗

Wound-like tumor periphery in human breast cancer predicts a convergent drug nonresponse

A significant portion of breast cancer patients are nonresponsive to well-established drugs and destined for a poor outcome regardless of molecular subtype. Although several (multiparameter) molecular markers have predicted their resistance to some of these drugs, profound uniparameter markers predictive of a convergent nonresponse to all these drugs remain elusive. We employ co-registered standard-multiphoton histology to representatively sample a few peripheral niches of the primary tumor, so that hundreds of patients can be stratified with either a wound-like or non-wound tumor periphery. With no fitting variable, this simple uniparameter morphological marker is: (a) highly sensitive and specific to predict a multidrug-nonresponsive phenotype that accounts for the majority of recurrence or death, independent of the molecular subtype or related adjuvant drug selection, clinical endpoint (disease-free versus overall survival), and hosting medical center; (b) robust against intratumor heterogeneity and valid at the earliest clinicopathological stage; and (c) dominant in predicting prognosis in the context of routine clinicopathological markers. Considering the mechanistic link between a wound-like extracellular matrix and a microenvironment supporting migratory or mesenchymal tumor cells, we attribute these unusual capabilities to an epithelial-mesenchymal transition nature of the morphological marker long sought after by pathologists.

pathology↗

HCMV glycoprotein B subunit vaccine efficacy was mediated by non-neutralizing antibody effector functions

Human cytomegalovirus (HCMV) is the most common congenital infection worldwide, frequently causing hearing loss and brain damage in afflicted infants. A vaccine to prevent maternal acquisition of HCMV during pregnancy is necessary to reduce the incidence of infant disease. The glycoprotein B (gB) + MF59 adjuvant subunit vaccine platform is the most successful HCMV vaccine tested to-date, demonstrating approximately 50% efficacy in preventing HCMV acquisition in phase II trials. However, the mechanism of vaccine protection remains unknown. Plasma from 33 gB/MF59 vaccinees at peak immunogenicity was tested for gB epitope specificity as well as neutralizing and non-neutralizing anti-HCMV effector functions, and compared to an HCMV-seropositive cohort. gB/MF59 vaccination elicited IgG responses with gB-binding magnitude and avidity comparable to natural infection. Additionally, IgG subclass distribution was similar with predominant IgG1 and IgG3 responses induced by gB vaccination and HCMV infection. However, vaccine-elicited antibodies exhibited limited neutralization of the autologous virus, negligible neutralization of multiple heterologous strains, and limited binding responses against gB structural motifs targeted by neutralizing antibodies including AD-1, AD-2, and Domain I. Interestingly, vaccinees had high-magnitude IgG responses against AD-3 linear epitopes, demonstrating immunodominance against this non-neutralizing, cytosolic region. Finally, vaccine-elicited IgG robustly bound trimeric, membrane-associated gB on the surface of transfected or HCMV-infected cells and mediated virion phagocytosis, though were poor mediators of NK cell activation. Altogether, these data suggest that non-neutralizing antibody functions, including virion phagocytosis, likely played a role in the observed 50% vaccine-mediated protection against HCMV acquisition.\n\nSignificanceThe CDC estimates that every hour, a child is born in the United States with permanent neurologic disability resulting from human cytomegalovirus (HCMV) infection - more than is caused by Down syndrome, fetal alcohol syndrome, and neural tube defects combined. A maternal vaccine to block transmission of HCMV to the developing fetus is a necessary intervention to prevent these adverse outcomes. The gB/MF59 vaccine is the most successful tested clinically to-date, achieving 50% reduction in HCMV acquisition. This manuscript establishes the function and epitope specificity of the humoral response stimulated by this vaccine that may explain the partial vaccine efficacy. Understanding the mechanism of gB/MF59-elicited protective immune responses will guide rational design and evaluation of the next generation of HCMV vaccines.

immunology↗